# CELLYAN BIOTECHNOLOGY CO LTD (HKPD)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/HKPD/

- Reporting holders: 6
- Reported value: $105.8K
- Shares held by institutions: 245,251 of 16,349,986 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [StoneX Group Inc.](https://holderbook.com/funds/913760-stonex-group-inc/) | $52.4K | 102,310 | 0.0% | 3 |
| [JANE STREET GROUP, LLC](https://holderbook.com/funds/1595888-jane-street-group-llc/) | $18.7K | 49,087 | 0.0% | 1 |
| [HRT FINANCIAL LP](https://holderbook.com/funds/1475597-hrt-financial-lp/) | $15.0K | 41,824 | 0.0% | 1 |
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $14.8K | 38,930 | 0.0% | 1 |
| [Clear Street Group Inc.](https://holderbook.com/funds/1881567-clear-street-group-inc/) | $4.6K | 12,019 | 0.0% | 4 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $411 | 1,081 | 0.0% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 6 | $105.8K |
| Q1 2026 | 4 | $35.5K |
| Q4 2025 | 4 | $60.7K |
| Q3 2025 | 2 | $17.8K |
| Q2 2025 | 6 | $93.5K |
| Q1 2025 | 4 | $55.8K |